Life science investigators use antibodies in a wide assortment of technologies and applications, creating a large, highly competitive marketplace for suppliers. In a recent survey of more than 1,100 researchers conducted by the market intelligence and consulting firm Frost & Sullivan and editors of The Scientist Magazine, 25 percent of respondents reported that their laboratories’ antibody reagent needs were not being met; 38 percent could not find a commercial supplier for their specific targets, species or applications. These statistics suggest that there are still significant opportunities for developing new products to meet the needs of researchers, and to profit from doing so. "The competitive landscape of the research antibodies market is expected to look very different in the next 5 years, with various companies growing much faster than the overall market,” says Christi Bird, a senior industry analyst at Frost & Sullivan. “Tapping into the areas where unmet needs and dissatisfaction exist will be key for antibody suppliers to gain market share.” Bird will share statistics collected in the survey, discuss the implications for antibody suppliers, and answer your market questions in this upcoming webinar.
Meet the Speaker
Christi Bird is a senior industry analyst with the Frost & Sullivan Life Sciences Team. Since joining the firm in 2007, she has authored several market analyses on life science tools, such as antibodies, next-generation sequencing, epigenetics and microRNA tools, and sample preparation. Prior to joining Frost & Sullivan, Bird was a scientific program analyst for the extramural division of the National Human Genome Research Institute.